Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 5/2011

01-05-2011 | Letter to the Editor

Juvenile and adult-onset systemic lupus erythematosus: an ethnicity-based comparison

Authors: Rui-Xue Leng, Qing-Qing Zhu, Hai-Feng Pan, Jin-Bao Feng, Jin-Hui Tao, Dong-Qing Ye

Published in: Rheumatology International | Issue 5/2011

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Hiraki LT, Benseler SM, Tyrrell PN et al (2008) Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. J Pediatr 152:550–556PubMed
2.
Brunner HI, Gladman DD, Iban˜ez D et al (2008) Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum 58:556–562PubMedCrossRef
3.
Reichlin M, Broyles TF, Hubscher O et al (1999) Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease. Arthritis Rheum 42:69–75PubMedCrossRef
4.
Pande IRA, Sekharan NG, Kailash S et al (1993) Analysis of clinical and laboratory profile in Indian childhood systemic lupus erythematosus and its comparison with SLE in adults. Lupus 2:83–87PubMedCrossRef
5.
Tucker LB, Menon S, Schaller JG et al (1995) Adult and childhood onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 34:866–872PubMedCrossRef
6.
Tucker LB, Uribe AG, Fernandez M et al (2008) Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus 17:314–323PubMedCrossRef
7.
Feng JB, Ni JD, Yao X et al (2009) Gender and age influence on clinical and laboratory features in Chinese patients with systemic lupus erythematosus: 1,790 cases. Rheumatol Int. doi:10.​1007/​s00296-009-1087-0
8.
Hoffman IE, Lauwerys BR, De Keyser F et al (2009) Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus. Ann Rheum Dis 68:412–415PubMedCrossRef
Metadata
Title
Juvenile and adult-onset systemic lupus erythematosus: an ethnicity-based comparison
Authors
Rui-Xue Leng
Qing-Qing Zhu
Hai-Feng Pan
Jin-Bao Feng
Jin-Hui Tao
Dong-Qing Ye
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 5/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1466-6

Other articles of this Issue 5/2011

Rheumatology International 5/2011 Go to the issue

Original Article

Effects of shock wave therapy in the skin of patients with progressive systemic sclerosis: a pilot study

Original Article

Evaluation of inflammatory change and bone erosion using a murine type II collagen-induced arthritis model

Case Report

Digital ulcers as the first manifestation of carpal tunnel syndrome

Review

The swollen joint, the thickened artery, and the smoking gun: tobacco exposure, citrullination and rheumatoid arthritis

Original Article

Role of sodium silicate in induction of scleroderma-related autoantibodies in brown Norway rats through oral and subcutaneous administration

Original Article

Health-related quality of life and its associations with mood condition in familial Mediterranean fever patients
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits